Filing Details

Accession Number:
0001104659-22-002361
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-07 18:11:53
Reporting Period:
2022-01-04
Accepted Time:
2022-01-07 18:11:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001316 Tg Therapeutics Inc. TGTX Pharmaceutical Preparations (2834) 363898269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538845 A Sean Power 2 Gansevoort Street, 9Th Floor
New York NY 10014
Cfo, Secretary And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-04 75,312 $19.20 578,136 No 4 S Direct
Common Stock Disposition 2022-01-05 9,653 $18.31 568,483 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  2. Includes shares of restricted Common Stock, which are subject to vesting and 140,000 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing.